Skip to content

Ginger Tablets effect on gestational diabetes

Double blinded Clinical trial of comparison between the effect of ginger and placebo on blood glucose in the women with gestational diabetes in two groups of ginger and placebo

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015090523897N1
Enrollment
80
Registered
2016-05-10
Start date
2016-01-10
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes. Diabetes mellitus arising in pregnancy

Interventions

Intervention 1: Intervention group will take ginger tablets which made by dineh company and contain 500 milligram of ginger, they will use 1500 milligram daily for 6 weeks. Intervention 2: Control gro
Treatment - Drugs
Intervention group will take ginger tablets which made by dineh company and contain 500 milligram of ginger, they will use 1500 milligram daily for 6 weeks.
Control groups take placebo tablets in dose 500 milligrams which are made by Dineh company and use 1500 milligrams of these placebos daily for 6 weeks.

Sponsors

Vice chancellor for research of Tarbiat Modares University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Pregnant women with one fetus in uterine; The women who their Fasting Blood Sugars are below of 92 in their first visit of prenatal care; The women with gestational diabetes diagnosis in 24-28 weeks of pregnancy; Lack of using drugs that affects blood sugar; Lack of having underlying disease such as cardiovascular, respiratory or renal diseases; The women who had normal Blood Sugar before pregnancy; Lack of hard exercise; Lack of need to insulin therapy by doctor diagnose; Women who candidate for low sugar diet treatment; exclusion criteria: any reaction of body and sensitivity to tablets

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Blood glucose. Timepoint: Before intervention, Six weeks after intervention. Method of measurement: Glucose Tolerance Test. Iin this test fast blood sugar of persons will measure and then 1 hour and 2 hours after using 75 gr glucose blood sugar of them will measure.;Resistance to insulin index. Timepoint: Before intervention, Six weeks after intervention. Method of measurement: Through measure of fast blood sugar and fasting insulin with formula.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahideh Jahanian

Tarbiat Modares University

shahideh.jahanian@modares.ac.ir+98 21 8801 3030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 27, 2026